Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 2017, Article ID 1286263, 8 pages
https://doi.org/10.1155/2017/1286263
Research Article

Impaired Hemorheology in Exacerbations of COPD

1Faculty of Medicine, Department of Pulmonology, Pamukkale University, Denizli, Turkey
2Faculty of Medicine, Department of Physiology, Pamukkale University, Denizli, Turkey

Correspondence should be addressed to Emine Kilic-Toprak; moc.oohay@enime_tp

Received 6 May 2017; Revised 7 August 2017; Accepted 21 August 2017; Published 27 September 2017

Academic Editor: Franz Stanzel

Copyright © 2017 Erhan Ugurlu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Vestbo, S. S. Hurd, A. G. Agustí et al., “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 4, pp. 347–365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Merinopoulou, M. Raluy-Callado, S. Ramagopalan, S. Maclachlan, and J. M. Khalid, “COPD exacerbations by disease severity in England,” International Journal of COPD, vol. 11, no. 1, pp. 697–709, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Duan, M. Zhou, J. Xiao et al., “Prediction of key genes and miRNAs responsible for loss of muscle force in patients during an acute exacerbation of chronic obstructive pulmonary disease,” International Journal of Molecular Medicine, vol. 38, no. 5, pp. 1450–1462, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Santos, A. Marin, J. Serra-Batlles et al., “Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation,” International Journal of COPD, vol. 11, no. 1, pp. 515–525, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Decramer, W. Janssens, and M. Miravitlles, “Chronic obstructive pulmonary disease,” The Lancet, vol. 379, no. 9823, pp. 1341–1351, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Lucantoni, D. Pietraforte, P. Matarrese et al., “The red blood cell as a biosensor for monitoring oxidative imbalance in chronic obstructive pulmonary disease: An ex vivo and in vitro study,” Antioxidants and Redox Signaling, vol. 8, no. 7-8, pp. 1171–1182, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Han, W. J. Poppinga, H. Zuo et al., “The novel compound Sul-121 inhibits airway inflammation and hyperresponsiveness in experimental models of chronic obstructive pulmonary disease,” Scientific Reports, vol. 6, Article ID 26928, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Osthoffa, C. Jenkins, and J. D. Leuppi, “Chronic obstructive pulmonary disease-A treatable disease,” Swiss Medical Weekly, vol. 143, Article ID w13777, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. K. J. Davis, S. H. Landis, Y.-M. Oh et al., “Continuing to confront COPD international physician survey: physician knowledge and application of COPD management guidelines in 12 countries,” International Journal of COPD, vol. 9, pp. 597–611, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Vestbo, R. Pauwels, J. A. Anderson, P. Jones, and P. Calverley, “Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease,” Thorax, vol. 60, no. 4, pp. 301–304, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. Global Strategy for the Diagnosis, Management and Prevention of COPD: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017, http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd. View at Publisher · View at Google Scholar · View at Scopus
  12. A. V. Muravyov, S. V. Draygin, N. N. Eremin, and A. A. Muravyov, “The microrheological behavior of young and old red blood cells in athletes,” Clinical Hemorheology and Microcirculation, vol. 26, pp. 183–188, 2002. View at Google Scholar
  13. M. J. Simmonds, H. J. Meiselman, and O. K. Baskurt, “Blood rheology and aging,” Journal of Geriatric Cardiology, vol. 10, no. 3, pp. 291–301, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. I. A. Tikhomirova, A. O. Oslyakova, and S. G. Mikhailova, “Microcirculation and blood rheology in patients with cerebrovascular disorders,” Clinical Hemorheology and Microcirculation, vol. 49, pp. 295–305, 2011. View at Google Scholar
  15. E. A. Stepovaya, V. V. Novitskiĭ, N. V. Ryazantseva, V. E. Gol'dberg, and etal., “Chronic bronchitis: participation of red cells in the pathologic process,” Klinicheskaia Meditsina, vol. 82, pp. 53–56, 2004. View at Google Scholar
  16. B. Ahmad, N. Ferrari, G. Montiel et al., “Influence of a moderate physical activity intervention on red cell deformability in patients suffering from chronic obstructive pulmonary disease (COPD),” Wiener Medizinische Wochenschrift, vol. 163, no. 13-14, pp. 334–339, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Ugurlu, E. Kilic-Toprak, G. Altinisik, and etal., “Increased erythrocyte aggregation and oxidative stress in patients with idiopathic interstitial pneumonia,” Sarcoidosis, Vasculitis and Diffuse Lung Diseases, vol. 33, pp. 308–316, 2016. View at Google Scholar
  18. I. P. Danilov and A. E. Makarevich, “Mechanisms of blood rheological disorders and their role in the progression of chronic obstructive bronchitis,” Terapevticheskii Arkhiv, vol. 57, no. 3, pp. 19–22, 1985. View at Google Scholar · View at Scopus
  19. J. Zhou, D. Wu, Y. Zhu, D. Ding, and F. Peng, “Hemorrheological status in patients with silicosis and its clinical significance,” Zhonghua Yu Fang Yi Xue Za Zhi, vol. 33, no. 6, pp. 348–350, 1999. View at Google Scholar · View at Scopus
  20. L. Coppola, G. Verrazzo, G. Esposito et al., “Hemorheological and cardiovascular effects of exercise training in the rehabilitation of elderly patients with chronic obstructive pulmonary disease,” Archives of Gerontology and Geriatrics, vol. 28, no. 1, pp. 1–8, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. A. B. Karul, F. Karadag, D. Kozaci, and C. Altun, “Erythrocyte fragility is not altered in stablechronic obstructive pulmonary diseasewith normal arterial pH,” Clinical Hemorheology and Microcirculation, vol. 28, pp. 107–112, 2003. View at Google Scholar
  22. O. N. Verbitskii, I. V. Buturov, and T. Iu. Purkh, “hemodynamics, blood gas composition and viscosity in patients with chronic obstructive bronchitis complicated by chronic cor pulmonale,” Probl Tuberk Bolezn Legk, vol. 7, pp. 42–45, 2004. View at Google Scholar
  23. E. Straface, P. Matarrese, L. Gambardella et al., “N-acetylcysteine counteracts erythrocyte alterations occurring in chronic obstructive pulmonary disease,” Biochemical and Biophysical Research Communications, vol. 279, no. 2, pp. 552–556, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Piagnerelli, K. Zouaoui Boudjeltia, D. Brohee et al., “Assessment of erythrocyte shape by flow cytometry techniques,” Journal of Clinical Pathology, vol. 60, no. 5, pp. 549–554, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. O. K. Baskurt, M. Boynard, G. C. Cokelet, and etal., “International expert panel for standardization of hemorheological methods. New guidelines for hemorheological laboratory techniques,” Clinical Hemorheology and Microcirculation, vol. 42, pp. 75–97, 2009. View at Google Scholar
  26. M. R. Hardeman, P. Goedhart, and S. Shin, “Methods in hemorheology,” in Handbook of Hemorheology and Hemodynamics, O. K. Baskurt, M. R. Hardeman, M. R. Rampling, and H. J. Meiselman, Eds., pp. 242–266, IOS Press, Amsterdam, The Netherlands, 2007. View at Google Scholar
  27. O. K. Baskurt and H. J. Meiselman, “Analyzing shear stress-elongation index curves: comparison of two approaches to simplify data presentation,” Clinical Hemorheology and Microcirculation, vol. 31, pp. 23–30, 2004. View at Google Scholar
  28. A. D. Lopez, K. Shibuya, C. Rao et al., “Chronic obstructive pulmonary disease: current burden and future projections,” European Respiratory Journal, vol. 27, no. 2, pp. 397–412, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. Global strategy for the diagnosis, management, and prevention of COPD: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014, http://www.goldcopd.org/.
  30. M. T. Santini, E. Straface, A. Cipri, M. Peverini, M. Santulli, and W. Malorni, “Structural alterations in erythrocytes from patients with chronic obstructive pulmonary disease,” Haemostasis, vol. 27, no. 4, pp. 201–210, 1997. View at Google Scholar · View at Scopus
  31. L. Yang, D. A. Andrews, and P. S. Low, “Lysophosphatidic acid opens a Ca++ channel in human erythrocytes,” Blood, vol. 95, no. 7, pp. 2420–2425, 2000. View at Google Scholar · View at Scopus
  32. J. R. Pawloski, D. T. Hes, and J. S. Stamler, “Export by red blood cells of nitric oxide bioactivity,” Nature, vol. 409, no. 6820, pp. 622–626, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. O. K. Baskurt and H. J. Meiselman, “Blood rheology and hemodynamics,” Seminars in Thrombosis and Hemostasis, vol. 29, no. 5, pp. 435–450, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. O. K. Baskurt, “Pathophysiological significance of blood rheology,” Turkish Journal of Medical Sciences, vol. 33, pp. 347–355, 2003. View at Google Scholar
  35. Z. Y. Wen, L. C. Song, Z. Y. Yan et al., “An animal model to study erythrocyte, senescence with a narrow time window of erythrocyte production: Alterations in osmotic fragility and deformability of erythrocytes during their life span,” Clinical Hemorheology and Microcirculation, vol. 19, pp. 299–306, 1998. View at Google Scholar
  36. G. Cicco and A. Pirrelli, “Red blood cell (RBC) deformability, RBC aggregability and tissue oxygenation in hypertension,” Clinical Hemorheology and Microcirculation, vol. 21, no. 3-4, pp. 169–177, 1999. View at Google Scholar · View at Scopus
  37. B. Hiebl, C. Mrowietz, S. Lee et al., “Influence of rheological parameters on the velocity of erythrocytes passing nailfold capillaries in humans,” Microvascular Research, vol. 48, pp. 129–139, 2011. View at Google Scholar
  38. O. K. Baskurt and H. J. Meiselman, “Erythrocyte aggregation: basic aspects and clinical importance,” Clinical Hemorheology and Microcirculation, vol. 53, pp. 23–27, 2013. View at Google Scholar
  39. R. Farah, R. Ibrahim, M. Nassar, D. Najib, Y. Zivony, and E. Eshel, “Neutrophil lymphocyte ratio better addition to CRP than CD64 index as marker for infection in COPD,” Panminerva Med, vol. 9, 2017. View at Publisher · View at Google Scholar
  40. E. Günay, S. Sarinç Ulaşli, O. Akar et al., “Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study,” Inflammation, vol. 37, no. 2, pp. 374–380, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Schäfer, V. O. Kheyfets, J. D. Schroeder et al., “Main pulmonary arterial wall shear stress correlates with invasive hemodynamics and stiffness in pulmonary hypertension,” Pulmonary Circulation, vol. 6, no. 1, pp. 37–45, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. H. H. Lipowsky, “Microvascular rheology and hemodynamics,” Microcirculation, vol. 12, no. 1, pp. 5–15, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. O. L. Osipova, V. E. Perleĭ, G. P. Orlova, A. I. U. Gichkin, and N. G. Iakovleva, “Blood rheological properties and their interrelation with pulmonary hypertension in patients with chronic dust bronchitis,” in Kliniceskaja Laboratornaja Diagnostika, vol. 8, pp. 30-31, 2004. View at Google Scholar
  44. V. Austin, P. J. Crack, S. Bozinovski, A. A. Miller, and R. Vlahos, “COPD and stroke: are systemic inflammation and oxidative stress the missing links?” Clinical Science, vol. 130, no. 13, pp. 1039–1050, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. J. E. Repine, A. Bast, and I. Lankhorst, “Oxidative stress in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 156, no. 2 I, pp. 341–357, 1997. View at Publisher · View at Google Scholar · View at Scopus
  46. P. A. Kirkham and P. J. Barnes, “Oxidative stress in COPD,” Chest, vol. 144, no. 1, pp. 266–273, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. U. Can, F. H. Yerlikaya, and S. Yosunkaya, “Role of oxidative stress and serum lipid levels in stable chronic obstructive pulmonary disease,” Journal of the Chinese Medical Association, vol. 78, no. 12, pp. 702–708, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. R. C. J. Langen, S. H. Korn, and E. F. M. Wouters, “ROS in the local and systemic pathogenesis of COPD,” Free Radical Biology and Medicine, vol. 35, no. 3, pp. 226–235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. W. MacNee, “Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease,” in Proceedings of the American Thoracic Society, vol. 2, pp. 50–60, Scotland, UK, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. W. Domej, K. Oettl, and W. Renner, “Oxidative stress and free radicals in COPD-implications and relevance for treatment,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 9, pp. 1207–1224, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. P. N. R. Dekhuijzen, K. K. H. Aben, I. Dekker et al., “Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease,” The American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 3, pp. 813–816, 1996. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Kostikas, G. Papatheodorou, K. Psathakis, P. Panagou, and S. Loukides, “Oxidative stress in expired breath condensate of patients with COPD,” Chest, vol. 124, no. 4, pp. 1373–1380, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. J. C. Mak, “Pathogenesis of COPD. Part II. Oxidative-antioxidative imbalance,” International Journal of Tuberculosis and Lung Disease, vol. 12, pp. 368–374, 2008. View at Google Scholar
  54. O. K. Baskurt, A. Temiz, and H. J. Meiselman, “Effect of superoxide anions on red blood cell rheologic properties,” Free Radical Biology and Medicine, vol. 24, no. 1, pp. 102–110, 1998. View at Publisher · View at Google Scholar · View at Scopus
  55. O. K. Baskurt and H. J. Meiselman, “Activated polymorphonuclear leukocytes affect red blood cell aggregability,” Journal of Leukocyte Biology, vol. 63, no. 1, pp. 89–93, 1998. View at Google Scholar · View at Scopus